ReviewJournal of pain research2026
Acupuncture for Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis with Trial Sequential Analysis.
Review in Journal of pain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Effective options for managing chemotherapy-induced peripheral neuropathy (CIPN) remain limited. Evidence supporting acupuncture for CIPN continues to accumulate, warranting a comprehensive synthesis to clarify its effects. Methods: We searched eight databases and extracted study characteristics from the included studies. We assessed risk of bias using the Cochrane RoB 2 tool and graded the certainty of evidence using the GRADE framework. Meta-analyses evaluated CIPN symptoms, clinical effectiveness rate (ER), nerve conduction study (NCS) parameters, and quantitative sensory testing (QST) outcomes. Prespecified subgroup, sensitivity, publication-bias, and trial sequential analyses (TSA) were conducted. Results: The review included 40 RCTs involving 2496 participants. Compared with controls, acupuncture interventions, used alone or with cointerventions, improved several CIPN symptom outcomes, including FACT-Ntx scores (MD = -1.43, 95% CI [-1.91, -0.95]) and increased the ER (RR = 1.74, 95% CI [1.57, 1.93]). Acupuncture also improved nerve conduction velocity and amplitude; however, no significant effects were found for worst pain scores, onset latency, or QST outcomes. GRADE rated the certainty of evidence for FACT-Ntx, EORTC QLQ-CIPN20, and ER as very low. TSA crossed the monitoring boundaries for FACT-Ntx, EORTC QLQ-CIPN20, and ER. Subgroup findings varied by acupuncture type, intervention purpose, and chemotherapy regimen. Conclusion: Both manual acupuncture and electroacupuncture were associated with higher ERs, whereas their effects on specific outcomes varied by intervention type, including whether acupuncture was combined with other treatments. LI4 and ST36 were the most frequently used acupoints, and distal hand and foot acupoints were also commonly selected. Future studies should assess how acupuncture modality, intervention purpose, and chemotherapy regimen influence outcomes. Because the certainty of evidence was very low, these findings should be interpreted cautiously.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.